Carl Icahn Icahn Carl
Carl Icahn is one of the most famous activist investors in U.S. markets, with decades of campaigns to change corporate strategy, capital allocation, and leadership. Through Icahn-related entities he has taken large stakes in companies he views as undervalued or poorly run. His approach combines financial engineering, board engagement, and public pressure to unlock shareholder value.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$784M |
| 2 |
HTZ
Hertz Global Holdings, Inc.
HTZ
|
+$559M |
| 3 |
Icahn Enterprises
IEP
|
+$333M |
| 4 |
American International
AIG
|
+$67.5M |
| 5 |
Xerox
XRX
|
+$66.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Herc Holdings
HRI
|
+$568M |
| 2 |
PayPal
PYPL
|
+$150M |
| 3 |
NUAN
Nuance Communications, Inc.
NUAN
|
+$144M |
| 4 |
ENZN
ENZON PHARMACEUTICALS INC
ENZN
|
+$2.77M |
| 5 |
SSE
SEVENTY SEVEN ENERGY INC COM
SSE
|
+$2.75M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 47.43% |
| 2 | Financials | 18.01% |
| 3 | Industrials | 11.69% |
| 4 | Consumer Discretionary | 6.62% |
| 5 | Materials | 5.71% |
Similar funds
Carl Icahn's Q2 2016 Portfolio in Review
As of Q2 2016, Carl Icahn held 23 positions worth $20.3B, down 5.6% from $21.5B the previous quarter. Its ten largest holdings account for 87% of the portfolio.
Carl Icahn deployed $941M of net new capital in Q2 2016, opening 2 new positions and adding to 3 existing holdings. Its largest new stake was Allergan plc: 3,400,000 shares worth $786M.
By sector, the portfolio is most concentrated in Energy at 47% of assets, down from 51% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was Herc Holdings, an estimated $568M trimmed.
- Carl Icahn's largest Q2 2016 buy was Allergan plc: 3,400,000 shares worth $786M.
- Carl Icahn added most to Icahn Enterprises in Q2 2016, an estimated $333M increase.
- Carl Icahn's biggest Q2 2016 reduction was Herc Holdings, cutting an estimated $568M.
- Carl Icahn fully exited ENZON PHARMACEUTICALS INC in Q2 2016, selling an estimated $2.77M.
- Carl Icahn's ten largest holdings make up 87% of its $20.3B portfolio in Q2 2016.
- Carl Icahn opened 2 new positions and closed 2 in Q2 2016.
- Carl Icahn's portfolio value fell 5.6% quarter-over-quarter to $20.3B.
Based on Icahn Carl's 13F filing for Q2 2016, filed 15 Aug 2016.